| NDC Code | 0008-0833-21 |
|---|
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0833-21) |
|---|
| Product NDC | 0008-0833 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Effexor |
|---|
| Proprietary Name Suffix | Xr |
|---|
| Non-Proprietary Name | Venlafaxine Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19971101 |
|---|
| End Marketing Date | 20251031 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA020699 |
|---|
| Manufacturer | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
|---|
| Substance Name | VENLAFAXINE HYDROCHLORIDE |
|---|
| Strength | 75 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
|---|